Primary Outcomes of an FDA IDE Trial of Spondyloplasty vs TLIF for Degenerative Spondylolisthesis

Authors

Rick C. Sasso
Todd F. Alamin
Javier Castro
Hyun W. Bae
Alan T. Villavicencio
Jeffrey L. Gum
Mick J. Perez-Cruet, Corewell Health
S Tim Yoon
William F. Lavelle
Jeffrey S. Fischgrund, Corewell Health

Document Type

Conference Proceeding

Publication Date

9-2024

Publication Title

The Spine Journal

Volume

24

Issue

9 Suppl

First Page

S116

Comments

North American Spine Society NASS 39th Annual Meeting, September 25-28, 2024, Chicago, IL

Last Page

S117

Recommended Citation

Sasso RC, AlaminTF, Castro J, Bae HW, Villavicencio AT, Gum JL, et al. [Perez-Cruet MJ, Fischgrund JS]. Primary outcomes of an FDA IDE trial of spondyloplasty vs TLIF for degenerative spondylolisthesis. Spine J. 2024 Sep;24(9 Suppl):S116-S117. doi: 10.1016/j.spinee.2024.06.132

DOI

10.1016/j.spinee.2024.06.132